Ultragenyx Pharmaceutical Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Novato, CA
RARE chart
What traders are saying about $RARE
Latest postsUltragenyx Pharmaceutical Inc. news
- Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Yahoo Finance ·
- Broadcom upgraded, HubSpot downgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Ultragenyx Pharmaceutical Inc. (RARE) stock price, news, quote and history
Yahoo Finance UK ·
- Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Yahoo Finance ·
- Ultragenyx Pharmaceutical (RARE) Set to Post Quarterly Earnings on Tuesday
MarketBeat ·
- Ultragenyx Pharmaceutical (RARE) Could Be 40% Undervalued As Turnaround Doubts Persist
Simply Wall Street ·
- Ultragenyx Pharmaceutical (RARE) Slips to $15.65 as Shares Test Lower Support Zone - Straddle Setup
https://www.siam.in/ ·
- Understanding Momentum Shifts in (RARE)
Stock Traders Daily ·
- Ultragenyx Pharmaceutical, Inc. Estimates – HAM:UP0
TradingView ·
- Form DEF 14A Ultragenyx Pharmaceutical Inc For: 21 October By Investing.com
Investing.com South Africa ·
- Piper Sandler Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $36
Moomoo ·
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $33.65 According to Brokerages
MarketBeat ·
Ultragenyx Pharmaceutical Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $673.0M | $560.0M | $434.0M | $363.3M |
| Net income | -$575.0M | -$569.0M | -$607.0M | -$707.4M |
| Diluted EPS | $-5.83 | $-6.29 | $-8.25 | $-10.12 |
| Total assets (year end) | $1.53B | $1.50B | $1.49B | $1.55B |
| Cash and equivalents (year end) | $421.0M | $174.0M | $214.0M | $132.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ultragenyx Pharmaceutical Inc.
- Ticker
- RARE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Novato, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1515673
Frequently asked questions
What exchange is Ultragenyx Pharmaceutical Inc. listed on?
Ultragenyx Pharmaceutical Inc. trades on the Nasdaq under the ticker symbol RARE.
What industry is Ultragenyx Pharmaceutical Inc. in?
Ultragenyx Pharmaceutical Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ultragenyx Pharmaceutical Inc. headquartered?
Ultragenyx Pharmaceutical Inc.'s business address on file with the SEC is in Novato, CA.
When does Ultragenyx Pharmaceutical Inc.'s fiscal year end?
Ultragenyx Pharmaceutical Inc.'s fiscal year ends on December 31.
How much revenue did Ultragenyx Pharmaceutical Inc. report?
Ultragenyx Pharmaceutical Inc. reported $673.0M in revenue for calendar year 2025, according to its SEC filings.